A phase II, single-center, prospective, randomized, double-blind, parallel and placebo-controlled pilot clinical study to assess the efficacy and safety of NUTROPIN in combination with intensive rehabilitation in adults with spinal cord injury (SCI) and growth hormone deficiency (GHD).
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2018
Price : $35 *
At a glance
- Drugs Somatrogon (Primary)
- Indications Somatotropin deficiency; Spinal cord injuries
- Focus Therapeutic Use
- 25 Apr 2018 New trial record
- 20 Mar 2018 Results presented at The 100th Annual Meeting of the Endocrine Society.